M. Pescovitz
American Journal of Transplantation · 2004–2009
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts M. Pescovitz overall
Papers from M. Pescovitz's perspective
Ordered by how strongly the researchers M. Pescovitz trusts endorse each paper. Same corpus, a different order for every researcher.
- Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. (Journal of Clinical Oncology)
- Marginal zone B cells. (Annual Review of Immunology)
- Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. (Blood)
- Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. (New England Journal of Medicine)
- A systematic review of the associations between dose regimens and medication compliance. (Clinical Therapeutics)
- Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy1 (Journal of Immunology)
- Diabetes Mellitus After Kidney Transplantation in the United States (American Journal of Transplantation)
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
- BAFF AND APRIL: a tutorial on B cell survival. (Annual Review of Immunology)
- Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function (2009) — 1,013 citations
- Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus (2007) — 627 citations
- Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action (2006) — 608 citations
- Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients (2004) — 835 citations